Socio-economic costs of osteoarthritis: A systematic review of cost-of-illness studies

Published on Apr 1, 2015in Seminars in Arthritis and Rheumatism5.07
· DOI :10.1016/j.semarthrit.2014.10.012
Jaume Puig-Junoy23
Estimated H-index: 23
(UPF: Pompeu Fabra University),
Alba Ruiz Zamora1
Estimated H-index: 1
(UPF: Pompeu Fabra University)
Abstract Objective The burden of illness that can be attributed to osteoarthritis is considerable and ever increasing. The aim of this systematic review is to analyze currently available data derived from cost-of-illness studies on the healthcare and non-healthcare costs of osteoarthritis. Methods PubMed, Index Medicus Espanol (IME), and the Spanish Database of Health Sciences [ Indice Bibliografico Espanol en Ciencias de la Salud (IBECS)] were searched up to the end of April 2013. This study adhered to the PRISMA guidelines. Articles were reviewed and the study quality assessed by two independent investigators with consensus resolution of discrepancies. Results We identified 39 studies that investigated the socio-economic cost of osteoarthritis. Only nine studies took a social perspective. Rather than estimating the incremental cost of osteoarthritis, nine studies estimated the total cost of treating patients with osteoarthritis without a control for comorbidity. The other 30 studies determined the incremental cost with or without a control group. Only nine studies assessed a comprehensive list of healthcare resources. The annual incremental healthcare costs of generalized osteoarthritis ranged from €705 to €19,715. The annual incremental non-healthcare-related costs of generalized osteoarthritis ranged from €432 to €11,956. Conclusions The study concludes that the social cost of osteoarthritis could be between 0.25% and 0.50% of a country׳s GDP. This should be considered in order to foster studies that take into account both healthcare and non-healthcare costs.
  • References (65)
  • Citations (41)
#1Kevin J. Bozic (UCSF: University of California, San Francisco)H-Index: 53
#2Brett R. Stacey (OHSU: Oregon Health & Science University)H-Index: 30
Last.Gerry OsterH-Index: 51
view all 5 authors...
#1T. Kim Le (Eli Lilly and Company)H-Index: 2
#2Leslie Montejano (Thomson Reuters)H-Index: 7
Last.Dennis C. Ang (IU: Indiana University)H-Index: 20
view all 5 authors...
#1Alvin Chen (Imperial College London)H-Index: 5
#2Chinmay Gupte (Imperial College London)H-Index: 22
Last.Justin Cobb (Imperial College London)H-Index: 30
view all 5 authors...
#1Job Hermans (EUR: Erasmus University Rotterdam)H-Index: 4
#2Marc A. Koopmanschap (EUR: Erasmus University Rotterdam)H-Index: 51
Last.Alex Burdorf (EUR: Erasmus University Rotterdam)H-Index: 58
view all 7 authors...
Cited By41
#1Jaynal Abedin (National University of Ireland, Galway)H-Index: 1
#2Joseph Antony (DCU: Dublin City University)H-Index: 3
Last.John Newell (National University of Ireland, Galway)H-Index: 30
view all 7 authors...
#1Laetitia Keller (UDS: University of Strasbourg)H-Index: 9
#2Luc Pijnenburg (UDS: University of Strasbourg)
Last.Enrique Gómez Barrena (UAM: Autonomous University of Madrid)H-Index: 1
view all 12 authors...
#1Xiaohui Zhao (WVU: West Virginia University)H-Index: 1
#2Drishti Shah (WVU: West Virginia University)H-Index: 1
Last.Usha Sambamoorthi (WVU: West Virginia University)H-Index: 30
view all 7 authors...
#1R.E. Miller (Rush University Medical Center)H-Index: 17
#2Carla R. Scanzello (UPenn: University of Pennsylvania)H-Index: 14
Last.Anne-Marie Malfait (Rush University Medical Center)H-Index: 32
view all 0 authors...
#1Elisa Belluzzi (UNIPD: University of Padua)H-Index: 11
#2Elena Stocco (UNIPD: University of Padua)H-Index: 4
Last.Marco Rossato (UNIPD: University of Padua)H-Index: 33
view all 12 authors...
#1G. Ruan (Anhui Medical University)H-Index: 2
#2Jianming Xu (Anhui Medical University)H-Index: 73
Last.Z. Zhu (Southern Medical University)H-Index: 9
view all 11 authors...
View next paperOsteoarthritis: A disease of the joint as an organ